Anesthesia Monitoring Devices Market

Executive Summary

Anesthesia Monitoring Devices Market was valued at US $4.01 billion in 2021 and is projected to grow at 12.26% CAGR over the forecast period to reach US $8.02 billion by 2027. Anesthesia Monitoring Devices Market represented US $0.83 billion opportunity over 2019-2021 and estimated to create US $4.01 billion opportunity in 2027 over 2021.

Anesthesia Monitoring Devices from Consainsights analyses the Anesthesia Monitoring Devices Market in the Life Sciences industry over the forecast period to 2027.

Anesthesia Monitoring Devices research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Anesthesia Monitoring Devices segmentation includes Product, End User, Geography and Geography.

Based on the Product, the Anesthesia Monitoring Devices analysis covers Advanced Anesthesia Monitors, Basic Anesthesia Monitors, Integrated Anesthesia Workstations, Others (It Enabled Monitors).

In Product segment, Advanced Anesthesia Monitors segment has highest cagr growth of 10.83%.

Based on the End User, the Anesthesia Monitoring Devices analysis covers Hospitals, Ambulatory Surgery Centers.

In End User segment, Hospitals segment has highest cagr growth of 10.83%.

Based on the Geography, the Anesthesia Monitoring Devices analysis covers North America, Europe, Asia-pacific, Rest Of The World.

In Geography segment, North America segment has highest cagr growth of 10.83%.

Based on the region, the Anesthesia Monitoring Devices analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Masimo, Fukuda Denshi, Infinium Medical, Covidien Plc (A Subsidiary Of Medtronic Plc.), Ge Healthcare (Division Of General Electric Company), Nihon Kohden Corporation, Philips Healthcare (A Subsidiary Of Royal Philips Electronics), Mindray Medical International Limited, Drägerwerk Ag & Co. Kgaa, Schiller Ag, Criticare Systems, Inc. (Stepdown Subsidiary Company Of Opto Circuits (India) Ltd.), Heyer Medical Ag. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Advanced Anesthesia Monitors segment has the highest revenue of US $1.49 billion and is expected to grow at CAGR of 10.83% by 2027 Advanced Anesthesia Monitors segment has highest cagr growth of 10.83%.

Advanced Anesthesia Monitors

Advanced Anesthesia Monitors segment was valued at US $1.18 billion in 2019 and is projected to grow at 10.83% CAGR over the forecast period to reach US $2.98 billion by 2027. Advanced Anesthesia Monitors segment represented US $0.31 billion opportunity over 2019-2021 and estimated to create US $1.49 billion opportunity in 2027 over 2021.

Basic Anesthesia Monitors

Basic Anesthesia Monitors segment was valued at US $1.10 billion in 2019 and is projected to grow at 10.83% CAGR over the forecast period to reach US $2.77 billion by 2027. Basic Anesthesia Monitors segment represented US $0.29 billion opportunity over 2019-2021 and estimated to create US $1.39 billion opportunity in 2027 over 2021.

Integrated Anesthesia Workstations

Integrated Anesthesia Workstations segment was valued at US $0.77 billion in 2019 and is projected to grow at 10.83% CAGR over the forecast period to reach US $1.94 billion by 2027. Integrated Anesthesia Workstations segment represented US $0.20 billion opportunity over 2019-2021 and estimated to create US $0.97 billion opportunity in 2027 over 2021.

Others (It Enabled Monitors)

Others (It Enabled Monitors) segment was valued at US $0.13 billion in 2019 and is projected to grow at 10.83% CAGR over the forecast period to reach US $0.33 billion by 2027. Others (It Enabled Monitors) segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.17 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals segment has the highest revenue of US $2.16 billion and is expected to grow at CAGR of 10.83% by 2027 Hospitals segment has highest cagr growth of 10.83%.

Hospitals

Hospitals segment was valued at US $1.71 billion in 2019 and is projected to grow at 10.83% CAGR over the forecast period to reach US $4.32 billion by 2027. Hospitals segment represented US $0.45 billion opportunity over 2019-2021 and estimated to create US $2.16 billion opportunity in 2027 over 2021.

Ambulatory Surgery Centers

Ambulatory Surgery Centers segment was valued at US $1.47 billion in 2019 and is projected to grow at 10.83% CAGR over the forecast period to reach US $3.70 billion by 2027. Ambulatory Surgery Centers segment represented US $0.38 billion opportunity over 2019-2021 and estimated to create US $1.85 billion opportunity in 2027 over 2021.

Geography

Introduction

In 2021, North America segment has the highest revenue of US $2.22 billion and is expected to grow at CAGR of 10.83% by 2027 North America segment has highest cagr growth of 10.83%.

North America

North America segment was valued at US $1.76 billion in 2019 and is projected to grow at 10.83% CAGR over the forecast period to reach US $4.44 billion by 2027. North America segment represented US $0.46 billion opportunity over 2019-2021 and estimated to create US $2.22 billion opportunity in 2027 over 2021.

Europe

Europe segment was valued at US $0.66 billion in 2019 and is projected to grow at 10.83% CAGR over the forecast period to reach US $1.66 billion by 2027. Europe segment represented US $0.17 billion opportunity over 2019-2021 and estimated to create US $0.83 billion opportunity in 2027 over 2021.

Asia-pacific

Asia-pacific segment was valued at US $0.62 billion in 2019 and is projected to grow at 10.83% CAGR over the forecast period to reach US $1.57 billion by 2027. Asia-pacific segment represented US $0.16 billion opportunity over 2019-2021 and estimated to create US $0.79 billion opportunity in 2027 over 2021.

Rest Of The World

Rest Of The World segment was valued at US $0.14 billion in 2019 and is projected to grow at 10.83% CAGR over the forecast period to reach US $0.34 billion by 2027. Rest Of The World segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.17 billion opportunity in 2027 over 2021.